• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Research Round-Up, by Blossom

Floris Wolswijk by Floris Wolswijk
October 14, 2022
in Science
Reading Time: 4 mins read
A A

Twice a month, our friends from Blossom will update you on the latest in psychedelic research. Enjoy an in-depth look at major studies and updates on recent psychedelic publications.

 

Lasting positive changes in mindfulness after a psilocybin experience

Scrolling the latest feeds on Instagram and TikTok and losing an hour doing so, who hasn’t experienced it? We all go through life partly on autopilot. This might be beneficial when brushing teeth or tying shoelaces, but it also means we’re missing the plot as life scrolls by.

The opposite of mindlessness is mindfulness: being aware of the present moment, acknowledging (but not getting lost in) and accepting one’s feelings, thoughts, and bodily sensations. Mindfulness is one of the outcomes of meditation and something most of us hope to have more off.

Besides being present, mindfulness is also associated with more openness to new experiences, a positive outlook on life, and less neuroticism. In other words, those who are more mindful also have greater psychological health. Modern forms of behavioural therapy, such as Acceptance and Commitment Therapy (ACT), incorporate mindfulness into their practice.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

New research into the effects of psychedelics, specifically psilocybin, argues that mindfulness is increased after one or two high doses. The psychedelic experience shares many aspects with being mindful, but do the effects last beyond the acute experience?

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

A more complete mystical experience predicts more mindfulness three months later

Researchers from Copenhagen University have put this hypothesis to the test. Earlier work found that mindfulness increased in those who had a psychedelic experience. But all previous studies were done either with a very small group of participants or experienced meditators.

In the current study, 42 participants received a high dose of psilocybin and psychological support. The study was done with healthy participants, and no specific therapy was given. Both mindfulness, before and three months after, and mystical experiences, directly after, were measured.

On average, participants reported being 8% more mindful three months after the completion of the study. This change, on a trait that usually doesn’t change throughout life, is similar to that found in people who followed an eight-week mindfulness course. In other words, the sustained change from a psychedelic experience is comparable to over 20 hours of mindfulness practice.

So far, the study has confirmed earlier results in a larger sample. New in this study is that the intensity of the mystical experience (measured with the Mystical Experience Questionnaire) also significantly correlated with mindfulness three months later. Those who had a more intense acute experience were also the people who reported the most significant change in mindfulness.

Though limited by the open-label design, meaning all participants knew they received psilocybin, the study highlights another mechanism through which psychedelics can have lasting positive effects. For these participants, one high-dose psilocybin session boosted their mindfulness by 8%.

 

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

More psychedelic research news…

Order Lasix Medicine Online

 

Shared brain connectivity among those in an ayahuasca ceremony

Each brain has a specific fingerprint of connections. This fingerprint is called the functional connectome. An fMRI study investigated how this changed when experienced ayahuasca users participated in a Santo Daime church ceremony.

Though each person’s fingerprint remained separated from the rest, a shared image formed. Switching analogies, it means that each person kept their unique hairstyle, but all were now wearing the same t-shirt.

 

Findings from two survey studies on psychedelic use and health outcomes

Two analyses of population survey data examined the correlation between psychedelic use and health outcomes. The first study looked at Americans who use MDMA and reported them having a more favorable body mass, fewer heart conditions, cancer, hypertension, or diabetes.

The second study looked closely at the favorable connection between MDMA and psilocybin, and lower psychological distress and suicidality. It finds that for white participants, there was a strong effect. However, for minorities, the benefits of MDMA and psilocybin use were much smaller, showing no relationship for Back, Indigenous, and Multiracial participants.

 

A ‘flatter’ brain landscape under the influence of LSD

If you imagine a signal traveling across the brain as moving between different peaks, then the higher the hills, the less likely a signal is to go to from one area to the next. Under the influence of LSD, the peaks are lowered (e.g. moving from Switzerland to The Netherlands), and you can say that the brain is more flexible.

The current fMRI study (that also used other brain measures) reports on this change and argues that a brain under the influence of LSD is less controlled top-down and that more bottom-up processing can take place.

 

Interested in more like this? Check out previous editions of the Psychedelic Research Round-Up

Tags: science
Floris Wolswijk

Floris Wolswijk

Floris is the founder of Blossom. He couldn’t find a place that explained the science of psychedelics in a way that most people could understand. He was missing a place that went beyond Google Scholar searches but was not as dense as an academic book. After not finding such a resource for psychedelics (as medicine), he founded Blossom in September 2019. Floris has a master’s degree (MSc) in Psychology (2008-2012) from the Erasmus University in Rotterdam, The Netherlands. After university, he co-founded a start-up in a different field. He fell in love with the psychedelics field through his first personal experiences with psychedelics and subsequently an encounter with the scientific literature. He hopes to play a small part in making psychedelics more widely available and used both in medicine and for self-development.

Next Post

News You Might Have Missed: Oct 17th, 2022

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.